Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
Article Details
- CitationCopy to clipboard
Sircar JC, Schwender CF, Carethers ME
Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
Biochem Pharmacol. 1983 Jan 1;32(1):170-2.
- PubMed ID
- 6131674 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Aminosalicylic acid Arachidonate 5-lipoxygenase Protein Humans UnknownInhibitorDetails Mesalazine Arachidonate 5-lipoxygenase Protein Humans YesInhibitorDetails Sulfasalazine Arachidonate 5-lipoxygenase Protein Humans YesInhibitorDetails